Furthermore, KRAS was shown to upregulate the enzyme asparagine synthetase in colorectal cancer via the PI3K-AKT-mTOR pathway, which allows cells to survive and proliferate upon glutamine depletion. This evidence concerns the gene KRAS and colorectal cancer.